IRUBIS
Germany
- Munich, Bavaria
- 03/09/2024
- Pre Series A
- Undisclosed Amount
IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing.
IRUBIS is a company that specializes in mid-infrared (MIR) spectroscopy for bioprocessing. We have designed an instrument, Monipa, specifically for bioprocess monitoring and control.
Monipa is based on MIR spectroscopy, making it possible to monitor multiple bioprocesses real-time and continuously. Our instrument's applications are foreseen in both upstream and downstream bioprocessing. These include multiple metabolite monitoring and control in upstream processing. In addition, contaminant detection or monitoring of target proteins and excipients can be aided in downstream processing.
Read more about our products and innovations at www.irubis.com.
- Industry Biotechnology Research
- Website https://irubis.com/
- LinkedIn https://www.linkedin.com/company/irubis/
Tolemy Bio | $1,643,411 | (May 13, 2026)
Basata | $21,000,000 | (May 13, 2026)
Corvera (YC W26) | $4,200,000 | (May 13, 2026)
4AM | $4,000,000 | (May 13, 2026)
Ciridae | $20,000,000 | (May 13, 2026)
Sedivention - Freezing the hunger feeling | $3,402,541 | (May 13, 2026)
Meatly | $14,074,996 | (May 13, 2026)
NanoStruct GmbH | $3,050,853 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)
Boundary | $2,000,000 | (May 13, 2026)
Algorithmiq | $21,122,550 | (May 13, 2026)
Knit Health | $11,600,000 | (May 13, 2026)